¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù.
Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº 2023³â Cell Reports ¿¡ ÃâÆǵÈ
'Accumulation of branched-chain amino acids reprograms glucose metabolism in CD8+ T cells with enhanced effector function and anti-tumor response'ÀÔ´Ï´Ù.
À§ ³í¹®Àº PP2Cm°áÇÌÀ¸·Î ÀÎÇÑ BCAA ÀÌÈÀÛ¿ëÀÇ ¼Õ»ó ¶Ç´Â ½ÄÀÌ º¸ÃæÀ¸·Î ÀÎÇÑ BCAAÀÇ ÃàÀûÀº Glut1ÀÇ »óÇâ Á¶Àý°ú ¼¼Æ÷ ³» ´ë»ç È°¼ºÀÇ ¸®¸ðµ¨¸µ¸¦ À¯¹ßÇÏ°í, ÀÌ´Â Çâ»óµÈ CD8+ T ¼¼Æ÷ ±â´ÉÀ» À¯µµÇÔÀ» ÀÔÁõÇÑ ³í¹®ÀÌ¿´½À´Ï´Ù.
PP2CM È¿¼Ò°¡ °áÇ̵Ǿî BCAA°¡ ÃàÀûµÇ´Â Çö»óÀÌ ¹ß»ýÇϸé Foxo1¿¡ ÀÇÁ¸ÀûÀ¸·Î glut1ÀÇ ¹ßÇöÀÌ ¼§Çâ Á¶ÀýµÇ°í ÀÌ¿¡ µû¶ó glucose uptake¾çÀÌ Áõ°¡ÇÏ¿´À¸¸ç,
ÀÌ´Â CD8 T cell metabolism reprogrammingÀ» À¯µµÇÏ¿© effector funtion°ú anti-tumor funtionÀ» Çâ»ó½ÃÅ´À» È®ÀÎÇÏ¿´½À´Ï´Ù.
ÀÌ·¯ÇÑ °á°ú´Â Human¿¡¼µµ immune checkpoint therapy¸¦ ¹ÞÀ» ¶§ ³ôÀº BCAA¸¦ Æ÷ÇÔÇÏ°í Àִ ȯÀÚÀÇ ´õ ³ªÀº ¿¹ÈÄ¿Í anti-PD-I°úÀÇ ½Ã³ÊÁö È¿°ú¸¦ È®ÀÎÇÏ¿© clinical significance±îÁö ¿¬°áÁö¾ú½À´Ï´Ù.
ÀÌ ³í¹®Àº CD8 T cell metabolism°ú effector functionÀ» ¿¬°áÁþ´Â È帧¿¡ ´ëÇؼ Âü°íÇÏ°íÀÚ °øºÎÇÏ¿´½À´Ï´Ù.